KRAS and pancreatic neoplasm: KRAS MASI is associated with worse prognosis in colorectal cancer and pancreatic cancer [44] and loss of the WT KRAS allele has been found at a higher rate in metastatic KRAS-mutated lung and pancreatic cancers compared to the primary tumors [36,37].